Ovarian Cancer Trial, Not Yet Recruiting NCT07465575 Sponsor: Liaquat University of Medical & Health Sciences Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Not Yet Recruiting

NCT07465575
Not Yet Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a woman between 18 and 40 years old
  • You have been diagnosed with polycystic ovary syndrome (PCOS) using a specific set of medical guidelines called the Rotterdam criteria (confirm with trial site)
  • Your body mass index (BMI) is 25 or above, which is generally considered overweight or obese
  • Tests have shown that your body has difficulty responding to insulin, a condition known as insulin resistance (confirm with trial site)
  • You are willing to follow healthy lifestyle advice, including changes to your diet and physical activity levels
  • You are able to read, understand, and sign a consent form agreeing to take part

Who may not be able to join:

  • You are currently pregnant or breastfeeding
  • You have taken medication to help your body use insulin better (such as metformin) in the last 3 months
  • You are currently taking hormonal treatments, such as the contraceptive pill or medicines that reduce male hormones
  • You have been diagnosed with diabetes
  • You have a known condition affecting your liver, kidneys, heart, or other hormone-related conditions apart from PCOS
  • You have taken any supplements containing berberine (a natural compound) in the last 3 months
  • You have a known allergy or sensitivity to berberine or similar substances

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Liaquat University of Medical & Health Sciences
Registry
ClinicalTrials.gov
Start date
16 March 2026
Est. completion
19 February 2027

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Change in Ferriman-Gallwey Score (Hirsutism); Change in Cardiff Acne Disability Index (CADI) Score; Change in Body Mass Index (BMI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov